Factors controlling the substrate specificity of peroxidases: kinetics and thermodynamics of the reaction of horseradish peroxidase compound I with phenols and indole-3-acetic acids.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 9188707)

Published in Biochemistry on June 10, 1997

Authors

L P Candeias1, L K Folkes, P Wardman

Author Affiliations

1: Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, Middlesex, U.K. candeias@graylab.ac.uk

Articles by these authors

Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res (1976) 3.44

The use of nitroaromatic compounds as hypoxic cell radiosensitizers. Curr Top Radiat Res Q (1977) 1.63

Mammalian cell toxicity of nitro compounds : dependence upon reduction potential. Biochem Biophys Res Commun (1976) 1.53

Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. Int J Radiat Biol Relat Stud Phys Chem Med (1979) 1.47

Interaction of dGMP radical with cysteamine and promethazine as possible model of DNA repair. Nature (1974) 1.42

Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol (1988) 1.28

Kinetics and mechanisms of hypochlorous acid reactions. Arch Biochem Biophys (1995) 1.28

Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (R Coll Radiol) (2013) 1.24

Oxygen inhibition of nitroreductase: electron transfer from nitro radical-anions to oxygen. Biochem Biophys Res Commun (1976) 1.20

Cytochrome C is a potent catalyst of dichlorofluorescin oxidation: implications for the role of reactive oxygen species in apoptosis. Biochem Biophys Res Commun (2001) 1.19

The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys (1988) 1.17

Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett (1993) 1.17

Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: dependence on reduction potential. J Natl Cancer Inst (1980) 1.14

Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochem Pharmacol (2001) 1.07

Cellular uptake of misonidazole and analogues with acidic or basic functions. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.02

Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems. J Med Chem (1992) 1.00

Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio. Int J Radiat Biol Relat Stud Phys Chem Med (1979) 0.98

Free-radical repair by a novel perthiol: reversible hydrogen transfer and perthiyl radical formation. Free Radic Res (1994) 0.96

Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet (2000) 0.95

Kinetics of superoxide scavenging by glutathione: an evaluation of its role in the removal of mitochondrial superoxide. Biochem Soc Trans (2003) 0.94

Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron(II) complex. Free Radic Res (1994) 0.93

Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther (2000) 0.93

Perthiols as antioxidants: radical-scavenging and prooxidative mechanisms. Methods Enzymol (1995) 0.92

Measurement of oxygen tension in tumours by time-resolved fluorescence. Br J Cancer Suppl (1996) 0.92

One-electron reduction of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents. J Med Chem (1986) 0.91

Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions. Mol Cancer Ther (2001) 0.90

Some reactions and properties of nitro radical-anions important in biology and medicine. Environ Health Perspect (1985) 0.89

Enhancement of lipid peroxidation by indole-3-acetic acid and derivatives: substituent effects. Free Radic Res (1995) 0.89

Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor. Radiat Res (1997) 0.89

Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents. Clin Chim Acta (2001) 0.88

Peroxidase-catalyzed effects of indole-3-acetic acid and analogues on lipid membranes, DNA, and mammalian cells in vitro. Biochem Pharmacol (1999) 0.87

Toward targeted "oxidation therapy" of cancer: peroxidase-catalysed cytotoxicity of indole-3-acetic acids. Int J Radiat Oncol Biol Phys (1998) 0.86

Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains. Int J Radiat Biol Relat Stud Phys Chem Med (1980) 0.86

Ruby laser irradiation (694 nm) of human skin biopsies: assessment by electron spin resonance spectroscopy of free radical production and oxidative stress during laser depilation. Photochem Photobiol (1999) 0.86

A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799. Br J Radiol (1986) 0.85

Radiosensitization by non-nitro compounds. Int J Radiat Oncol Biol Phys (1982) 0.85

Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro. J Med Chem (1998) 0.85

Nitric oxide in biological fluids: analysis of nitrite and nitrate by high-performance ion chromatography. J Chromatogr A (1995) 0.85

Free radical intermediates in the oxidation of flavone-8-acetic acid: possible involvement in its antitumour activity. Free Radic Biol Med (1993) 0.83

Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976. Radiat Res (2012) 0.83

Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase. Biochem Pharmacol (1980) 0.83

The measurement of hypoxia in tumours. BJR Suppl (1992) 0.83

Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding. Biochem Pharmacol (1991) 0.82

Reactivity of thiols towards derivatives of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents. Chem Biol Interact (1987) 0.81

Fluorescent markers for hypoxic cells: a study of nitroaromatic compounds, with fluorescent heterocyclic side chains, that undergo bioreductive binding. J Med Chem (1991) 0.81

The rationale for the development of improved hypoxic cell radiosensitizers. Br J Cancer Suppl (1978) 0.81

Are ortho-substituted 4-nitroimidazoles a new generation of radiation-induced arylating agents? Int J Radiat Biol Relat Stud Phys Chem Med (1980) 0.80

The reaction of oxygen with radicals from oxidation of tryptophan and indole-3-acetic acid. Biophys Chem (1997) 0.80

The one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): a hypoxia-selective bioreductive drug. Free Radic Res (1996) 0.79

Electron transfer reactions in RB90745, a bioreductive drug having both aromatic N-oxide and nitroarene moieties. Free Radic Res (1996) 0.79

Enzymic cis-trans isomerization of nitrofuran derivatives: isomerizing activity of xanthine oxidase, lipoyl dehydrogenase, DT-diaphorase and liver microsomes. Biochim Biophys Acta (1979) 0.79

Amplification of oxidative stress by decarboxylation: a new strategy in anti-tumour drug design. Biochem Soc Trans (1995) 0.78

Glutathione-reactive nitro compounds as radiosensitizers: mechanistic and therapeutic implications. Int J Radiat Oncol Biol Phys (1986) 0.78

Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase. Biochem Pharmacol (1982) 0.78

Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs. J Med Chem (1997) 0.78

Rates of reaction of indoleacetic acids with horseradish peroxidase compound I and their dependence on the redox potentials. Biochemistry (1996) 0.78

Nitroaryl compounds as potential fluorescent probes for hypoxia. I. Chemical criteria and constraints. Int J Radiat Oncol Biol Phys (1984) 0.78

Cis-trans isomerization of the (5-nitro-2-furyl)acrylamide, AF-2, initiated by ascorbate, glutathione, Fe(II) and OH-. Biochem Pharmacol (1984) 0.78

Oxidative denitrification of N omega-hydroxy-L-arginine by the superoxide radical anion. Biochem J (1996) 0.78

Nitroaryl compounds as potential fluorescent probes for hypoxia. II. Identification and properties of reductive metabolites. Int J Radiat Oncol Biol Phys (1984) 0.78

Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinones. Bioorg Med Chem Lett (1999) 0.77

Peroxidase activation of 1-naphthol to naphthoxy or naphthoxy-derived radicals and their reaction with glutathione. Chem Biol Interact (1986) 0.77

Increase in intracellular cysteine after exposure to dithiothreitol: implications in radiobiology. Int J Radiat Biol (1989) 0.77

Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities. Int J Radiat Biol (1994) 0.77

The uptake of the radiosensitizing compound Ro 03-8799 (Pimonidazole) in human tumors. Int J Radiat Oncol Biol Phys (1989) 0.76

Selective free radical reactions with proteins and enzymes: a reversible equilibrium in the reaction of (SCN)2 radical with lysozyme. Int J Radiat Biol Relat Stud Phys Chem Med (1982) 0.76

Hypoxia in biology and medicine: the legacy of L H Gray. Br J Radiol (2006) 0.76

Uptake and cytotoxicity of novel nitroimidazole-polyamine conjugates in Ehrlich ascites tumour cells. Biochem Pharmacol (1992) 0.76

Letter: Protonation of the radical-anions of nitro-imidazole radiosensitizers and the formation of radical-adducts. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 0.76

Influence of plasma glutathione levels on radiation mucositis. Int J Radiat Oncol Biol Phys (2001) 0.76

Nitric oxide involvement in the toxicity of hydroxyguanidine in leukaemia HL60 cells. Br J Cancer Suppl (1996) 0.75

Hypoxic cell radiosensitizers--chemical aspects and in vitro models. Strahlentherapie Sonderb (1978) 0.75

Bioreductively-activated prodrugs for targeting hypoxic tissues: elimination of aspirin from 2-nitroimidazole derivatives. Bioorg Med Chem Lett (1999) 0.75

Letter: Reactivity of a free radical probe with erythrocyte membranes. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 0.75

The kinetics of the reaction of 'anomalous' 4-nitroimidazole radiosensitizers with thiols. Int J Radiat Biol Relat Stud Phys Chem Med (1982) 0.75

Synthesis and activity of novel nitropyrazines for use as hypoxic cell radiosensitizers. J Med Chem (1984) 0.75

Reduction of nitroimidazoles in model chemical and biological systems. Int J Radiat Oncol Biol Phys (1982) 0.75

Molecular mechanisms of oxygen and "electron-affinic" radiosensitizers. Int J Radiat Oncol Biol Phys (1989) 0.75

Reductive role of glutathione in the redox cycling of oxidizable drugs. Biochem Pharmacol (1986) 0.75

Synthesis and properties of prodrugs activated in hypoxia to give bleomycin analogues. Bioorg Med Chem Lett (1998) 0.75

Correlation of the radiosensitization potency afforded by nitroacridine intercalators with their electron scavenging efficiency in DNA. Int J Radiat Oncol Biol Phys (1992) 0.75

Synthesis, hydroxyl radical production and cytotoxicity of analogues of bleomycin. Bioorg Med Chem (2000) 0.75

Oxidative denitrification of the antitumour drug hydroxyguanidine. Free Radic Biol Med (1998) 0.75

Nitroakridin 3582: a fluorescent nitroacridine stain for identifying hypoxic cells. Br J Radiol (1983) 0.75

Indolequinone bioreductive drugs: kinetic factors which influence selectivity for hypoxia. Anticancer Drug Des (1998) 0.75

Decarboxylation of the antitumour drugs flavone-8-acetic acid and xanthenone-4-acetic acid by nitrogen dioxide. Anticancer Drug Des (1994) 0.75

A pulse radiolysis study of some free radical reactions with erythrocyte membranes. Biochim Biophys Acta (1975) 0.75